In general, high expression of LRIG1 and LRIG3 in tumours is associated with improved survival in cancer patients, whereas high expression of LRIG2 is associated with poor survival even in early-stage cervical cancer patients [27]. The gene discussed is LRIG1; the disease is cervical cancer.